Project Grant HT94252411114

Award Date 9/30/24
Completion Date 12/31/25
Dollars Obligated $603K
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Westlake, MD 20817, USA
Similar Awards
The U.S. Department of the Army Medical Command awarded a $170,202 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant aims to "COMPARING COGNITIVE BEHAVIORAL THERAPY AND ACUPUNCTURE FOR MANAGING CHRONIC PAIN (COMBAT-PAIN)" with a performance period from September 30, 2024 to December 31, 2025. As part of this Project Grant, The University of...
This $1,994,937 federal Project Grant award, funded by the U.S. Department of Defense through the Military Medical Research and Development program (CFDA 12.420), is supporting research to confirm the effectiveness of acupuncture in treating the symptoms of Gulf War Illness. The grant recipient, Beth Israel Deaconess Medical Center, Inc. (Bidmc), a prominent academic medical center in Boston, will conduct this research project over a 4-year period from August 2024 to July 2028. Bidmc has...
This federal Project Grant award of $1,539,865.00, issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), is supporting research at the University of Utah to confirm the effectiveness of acupuncture in treating the symptoms of Gulf War Illness. The project, set to run from August 1, 2024 to July 31, 2028, will leverage the university's expertise in biomedical research and healthcare services to advance knowledge in this critical area. The...
This federal Project Grant award of $170,712.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research on the comparative effectiveness of exercise, cognitive behavioral therapy, and their combination for individuals with chronic musculoskeletal pain and poor sleep. The award, with a period of performance from September 30, 2024 to September 29, 2028, is funding research conducted by the University of Queensland in Australia. The...
This Project Grant award, valued at $399,729.00, was provided by the Department of Defense's Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports a research project focused on the clinical effectiveness of nonopioid pain management approaches to improve outcomes among active-duty service members. The award was granted to the University of Illinois, which will conduct this research over a 2-year period from November 1,...
This federal Project Grant award, totaling $1,012,894.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to investigate pain reprocessing therapy for veterans with chronic back pain. The 4-year award, with a start date of September 30, 2024, will compare the efficacy of this therapy and examine facilitators and barriers to implementation. The University of Colorado-Denver is the prime awardee, with sub-awards going to Texas...
The Defense Health Agency awarded a $2,206,031 project grant to Rush University Medical Center to fund the PREVENTING THE DEVELOPMENT OF CHRONIC PAIN: TREATING PTSD AT ACUTE PAIN ONSET program. The grant is part of the Military Medical Research and Development program (CFDA 12.420) and will support basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions for battlefield injuries. Specifically, the grant will fund...
The $890,826 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will support a study by the Denver Research Institute (DRI) to evaluate the comparative efficacy and implementation factors of Pain Reprocessing Therapy for veterans with chronic back pain. The four-year project, starting on September 30, 2024, will conduct research to assess the clinical effectiveness of this novel pain management approach and...
The Defense Health Agency awarded a $553,725 Project Grant to the University of California, Berkeley under the Military Medical Research and Development program (CFDA 12.420) to confirm the effectiveness of acupuncture in treating the symptoms of Gulf War Illness. The grant, which runs from August 1, 2024 to July 31, 2028, will enable UC Berkeley to conduct research to determine whether acupuncture provides a viable treatment option for the medical issues affecting veterans of the Gulf War. As a...
The federal Project Grant award, valued at $1,122,000.00 and awarded on July 15, 2023 by the Defense Health Agency, supports the University of North Carolina at Chapel Hill's research project titled "ENGAGING MOTOR CORTEX ANTINOCICEPTIVE CIRCUITS TO TREAT CHRONIC PAIN UNPLEASANTNESS". The project, funded through the Military Medical Research and Development program (CFDA 12.420), aims to study how engaging the motor cortex can be used to treat chronic pain. As a sub-award under this...

This federal Project Grant award of $602,900.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund a study comparing cognitive behavioral therapy and acupuncture for managing chronic pain, titled "COMPARING COGNITIVE BEHAVIORAL THERAPY AND ACUPUNCTURE FOR MANAGING CHRONIC PAIN (COMBAT-PAIN)". The award was made to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a non-profit research organization, with a performance period from September 30, 2024 to December 31, 2025. This research initiative aims to explore innovative approaches to improve healthcare for military service members and the broader public, focusing on conditions relevant to the military population.

Generated 7/1/25, 3:15 AM